SIG Group (SIGN) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
3 Mar, 2026Executive summary
Sequential improvement in Q4 2025 led to positive revenue growth after Q3 destocking, with full-year revenue up 0.4% at constant currency and resin, reaching the upper end of expectations.
Strategic review resulted in €351 million in non-recurring pre-tax charges, mainly for asset impairments and restructuring, with two asset disposals completed in China and Germany.
Innovation continued with new machine deployments, expansion of sustainable packaging solutions, and EcoVadis platinum status.
CEO transition occurred with Mikko Keto starting March 1, 2026, focusing on disciplined growth and operational execution.
68 new fillers placed in 2025, with a net increase of 14 after replacements and scrapping.
Financial highlights
Reported revenue for 2025 was €3,249 million, down from €3,329 million in 2024; at constant currency, revenue grew 0.4%.
Adjusted EBITDA was €718 million (22.1% margin); excluding non-recurring charges, €788 million (24.2% margin).
Adjusted EBIT was €442 million (13.6% margin); excluding non-recurring charges, €511 million (15.7% margin).
Adjusted net income was €231 million, or €285 million excluding non-recurring charges; EPS declined from €0.81 to €0.75.
Free cash flow was €191 million, down from €290 million in 2024.
ROCE was 25% (27% excluding non-recurring charges), down from 29% in 2024.
Outlook and guidance
2026 revenue growth expected to be flat to 2% at constant currency and resin, with adjusted EBIT margin guidance of 15.7%-16.2%.
Midterm guidance: 3%-5% revenue growth, EBIT margin above 16.5%, net CapEx at 6%-8% of revenue, and net leverage target below 2.5x by 2027.
Dividend payout paused for 2025; expected to resume at 30%-50% of adjusted net income in future years.
Latest events from SIG Group
- Carton growth offset bag-in-box weakness; margin and guidance were lowered for 2024.SIGN
H1 20242 Feb 2026 - Q3 revenue up 5.1% at constant currency; guidance and margin targets reaffirmed.SIGN
Q3 2024 TU18 Jan 2026 - Q1 2025 saw 3.2% revenue growth, margin gains, and guidance reaffirmed.SIGN
Q1 2025 TU24 Dec 2025 - 6% revenue growth, strong cash flow, and innovation; 2025 guidance set at 3%-5% growth.SIGN
H2 202423 Dec 2025 - H1 2025 revenue up 2.6% at constant currency, margin 23.6%, guidance narrowed.SIGN
H1 202516 Nov 2025 - Strategic reset targets core aseptic growth, margin uplift, and resumed dividends.SIGN
Investor Update31 Oct 2025 - Q3 2025 marked by revenue decline, major non-recurring charges, and paused 2025 dividend.SIGN
Q3 2025 TU28 Oct 2025